Cargando…
Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs
A CpG-containing DNA oligonucleotide functionalized with the 2-(N-formyl-N-methyl)aminoethyl thiophosphate protecting group (CpG ODN fma1555) was prepared from phosphoramidites 1a–d using solid-phase techniques. The oligonucleotide behaved as a prodrug by virtue of its conversion to the well-studied...
Autores principales: | Grajkowski, Andrzej, Pedras-Vasconcelos, Joao, Wang, Vivian, Ausín, Cristina, Hess, Sonja, Verthelyi, Daniela, Beaucage, Serge L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156963/ https://www.ncbi.nlm.nih.gov/pubmed/15972797 http://dx.doi.org/10.1093/nar/gki657 |
Ejemplares similares
-
Use of thermolytic protective groups to prevent G-tetrad formation in CpG ODN type D: structural studies and immunomodulatory activity in primates
por: Puig, Montserrat, et al.
Publicado: (2006) -
Permanent or reversible conjugation of 2′-O- or 5′-O-aminooxymethylated nucleosides with functional groups as a convenient and efficient approach to the modification of RNA and DNA sequences
por: Cieślak, Jacek, et al.
Publicado: (2012) -
CpG Oligonucleotides Protect Mice From Alphavirus Encephalitis: Role of NK Cells, Interferons, and TNF
por: Manangeeswaran, Mohanraj, et al.
Publicado: (2020) -
CpG Oligonucleotides as Cancer Vaccine Adjuvants
por: Shirota, Hidekazu, et al.
Publicado: (2015) -
The revival of CpG oligonucleotide-based cancer immunotherapies
por: Adamus, Tomasz, et al.
Publicado: (2018)